Burney Co. trimmed its stake in shares of CVS Health Co. (NYSE:CVS – Free Report) by 5.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 19,596 shares of the pharmacy operator’s stock after selling 1,129 shares during the period. Burney Co.’s holdings in CVS Health were worth $880,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors also recently bought and sold shares of CVS. MidAtlantic Capital Management Inc. acquired a new position in shares of CVS Health in the 3rd quarter valued at $25,000. Livelsberger Financial Advisory purchased a new position in CVS Health in the third quarter valued at $31,000. Legacy Investment Solutions LLC acquired a new position in shares of CVS Health in the third quarter worth about $31,000. Reston Wealth Management LLC purchased a new stake in shares of CVS Health during the 3rd quarter worth about $32,000. Finally, Kathleen S. Wright Associates Inc. purchased a new position in shares of CVS Health in the 3rd quarter valued at about $33,000. 80.66% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
CVS has been the topic of several research analyst reports. Truist Financial dropped their price objective on CVS Health from $67.00 to $60.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Mizuho cut their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a report on Thursday, October 24th. Barclays dropped their target price on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a research report on Thursday, November 7th. Royal Bank of Canada reduced their price target on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research report on Friday, November 15th. Finally, TD Cowen lifted their price objective on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a report on Monday, November 25th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $68.71.
CVS Health Stock Down 0.3 %
Shares of NYSE:CVS opened at $52.01 on Friday. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $80.75. The stock has a market cap of $65.44 billion, a P/E ratio of 13.20, a PEG ratio of 0.72 and a beta of 0.59. The business has a fifty day moving average of $51.49 and a two-hundred day moving average of $56.39. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.
CVS Health (NYSE:CVS – Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $0.01. The firm had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. CVS Health’s revenue was up 6.3% compared to the same quarter last year. During the same period last year, the business earned $2.21 earnings per share. On average, research analysts expect that CVS Health Co. will post 5.22 earnings per share for the current year.
CVS Health Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Investors of record on Thursday, January 23rd will be issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 5.11%. The ex-dividend date is Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is 67.51%.
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
See Also
- Five stocks we like better than CVS Health
- Industrial Products Stocks Investing
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- What is the S&P/TSX Index?
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- Insider Buying Explained: What Investors Need to Know
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.